Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Drug Rash Induced by Levothyroxine Tablets.

Choi YH, Choi WY, Kang HC, Koh YI, Bae EH, Kim SW.

Thyroid. 2012 Sep 4. [Epub ahead of print] No abstract available.

PMID:
22856642
[PubMed - as supplied by publisher]
2.

Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.

Koytchev R, Lauschner R.

Arzneimittelforschung. 2004;54(10):680-4.

PMID:
15553108
[PubMed - indexed for MEDLINE]
3.

Possible leaching of diethyl phthalate into levothyroxine sodium tablets.

Cafmeyer NR, Wolfson BB.

Am J Hosp Pharm. 1991 Apr;48(4):735-9.

PMID:
2042676
[PubMed - indexed for MEDLINE]
4.

A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers.

Yannovits N, Zintzaras E, Pouli A, Koukoulis G, Lyberi S, Savari E, Potamianos S, Triposkiadis F, Stefanidis I, Zartaloudis E, Benakis A.

Eur J Drug Metab Pharmacokinet. 2006 Apr-Jun;31(2):73-8.

PMID:
16898074
[PubMed - indexed for MEDLINE]
6.

Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.

Richheimer SL, Amer TM.

J Pharm Sci. 1983 Nov;72(11):1349-51.

PMID:
6644603
[PubMed - indexed for MEDLINE]
7.

Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxine.

Yamamoto T.

Thyroid. 2003 Dec;13(12):1177-81.

PMID:
14751040
[PubMed - indexed for MEDLINE]
8.

Effect of excipients on the stability of levothyroxine sodium tablets.

Das Gupta V, Odom C, Bethea C, Plattenburg J.

J Clin Pharm Ther. 1990 Oct;15(5):331-6.

PMID:
2289935
[PubMed - indexed for MEDLINE]
9.

Determination of liothyronine and levothyroxine in thyroid preparations by liquid chromatography.

Richheimer SL, Jensen CB.

J Pharm Sci. 1986 Feb;75(2):215-7.

PMID:
3514844
[PubMed - indexed for MEDLINE]
10.

Pseudomalabsorption of levothyroxine: a case report.

Ogawa D, Otsuka F, Mimura U, Ueno A, Hashimoto H, Kishida M, Ogura T, Makino H.

Endocr J. 2000 Feb;47(1):45-50.

PMID:
10811292
[PubMed - indexed for MEDLINE]
Free Article
11.

Stability of an extemporaneously compounded levothyroxine sodium oral liquid.

Boulton DW, Fawcett JP, Woods DJ.

Am J Health Syst Pharm. 1996 May 15;53(10):1157-61.

PMID:
8734676
[PubMed - indexed for MEDLINE]
12.

Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.

Di Girolamo G, Keller GA, de Los Santos AR, Schere D, Gonzalez CD.

Clin Ther. 2008 Nov;30(11):2015-23. doi: 10.1016/j.clinthera.2008.11.005.

PMID:
19108789
[PubMed - indexed for MEDLINE]
13.

In-use life of levothyroxine sodium tablets.

Das Gupta V.

J Clin Pharm Ther. 1991 Aug;16(4):299. No abstract available.

PMID:
1939409
[PubMed - indexed for MEDLINE]
14.

Liver injury induced by levothyroxine in a patient with primary hypothyroidism.

Kawakami T, Tanaka A, Negoro S, Morisawa Y, Mikami M, Hojo M, Yamamoto T, Uegaki S, Aiso M, Kawasaki T, Ishii T, Kuyama Y, Fukusato T, Takikawa H.

Intern Med. 2007;46(14):1105-8. Epub 2007 Jul 17.

PMID:
17634708
[PubMed - indexed for MEDLINE]
Free Article
15.

Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.

Colucci P, D'Angelo P, Mautone G, Scarsi C, Ducharme MP.

Ther Drug Monit. 2011 Jun;33(3):355-61. doi: 10.1097/FTD.0b013e318217b69f.

PMID:
21516059
[PubMed - indexed for MEDLINE]
16.

Potency of brand name and generic levothyroxine.

Stoffer SS, Szpunar WE.

JAMA. 1980 Oct 10;244(15):1704-5.

PMID:
7411829
[PubMed - indexed for MEDLINE]
17.

Application of extraction disks in dissolution tests of clenbuterol and levothyroxine tablets by capillary electrophoresis.

Carducci CN, Lucangioli SE, Rodríguez VG, Fernández Otero GC.

J Chromatogr A. 1996 Apr 12;730(1-2):313-9.

PMID:
8680592
[PubMed - indexed for MEDLINE]
18.

In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model.

Wood RW, Martis L, Gillum AW, Roseman TJ, Lin L, Bernardo P.

J Pharm Sci. 1990 Feb;79(2):124-7.

PMID:
2324959
[PubMed - indexed for MEDLINE]
19.

Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma.

Olveira G, Almaraz MC, Soriguer F, Garriga MJ, Gonzalez-Romero S, Tinahones F, Ruiz de Adana MS.

Clin Endocrinol (Oxf). 1997 Jun;46(6):707-11.

PMID:
9274701
[PubMed - indexed for MEDLINE]
20.

Levothyroxine-induced liver dysfunction in a primary hypothyroid patient.

Ohmori M, Harada K, Tsuruoka S, Sugimoto K, Kobayashi E, Fujimura A.

Endocr J. 1999 Aug;46(4):579-83.

PMID:
10580751
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk